Diabetes

In order to increase the effectiveness of adherence interventions, we need to take into account the fact that human beings are not always rational.

Researchers perform the most comprehensive evaluation of the cardiovascular risk of type 2 diabetes drug rosignlitazone ever completed.

These results provide insights into the genetic factors underlying the risk of T2D and may reveal strategies for reducing the risk among women who had gestational diabetes.

When combining a drug that is known to cause beta cells to proliferate with another drug that is already in widespread use in people with diabetes, it will cause the cells to proliferate at a rate of 5% to 6% per day, according to the study authors.

The duration of lactation was found to be a favorable glucose metabolic biomarker profile among women with a history of gestational diabetes mellitus.

Simplici-T1 is the first study to test activation of glucokinase in patients with type 1 diabetes by evaluating daily oral TTP399 as an adjunct to insulin therapy.

This month's OTC case studies ask about PMS symptoms, using stevia for diabetes, and OTC Tamiflu.

This activity is supported by an independent educational grant from Abbott Diabetes Care.

Both semaglutide and dulaglutide are dosed once weekly for treatment of type 2 diabetes.

The FDA has approved triple-combination extended release tablets to lower blood sugar in adults with type 2 diabetes (T2D), when combined with diet and exercise.

A recent study shows that diabetes risk is associated with younger age at onset of obesity, and longer exposure to obesity.

Lower-priced versions of Humalog Mix75/25 KwikPen and Humalog Junior KwikPen will be available in mid-April and will have 50% lower list prices compared with branded versions.

The treatment is the first and only fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation, according to Novo Nordisk.

The immunogenicity and safety of hepatitis B surface antigen (HBsAg)/CpG 1018 was assessed in patients with diabetes aged 60 to 70 years.

Results of the DAPA-HF trial demonstrate the efficacy and safety of dapagliflozin in patients with heart failure.

Rates of some vaccinations are low in these patients, but pharmacists can play a key role in adherence.

According to Janet Woodcock, MD and director of FDA’s Center for Drug Evaluation and Research, the agency is focused on the drugs used by Americans continuing to meet “strict quality standards.”

A new study has found that patients with heart failure with reduced ejection fraction receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular events.

The approval was based on a phase 3 EDITION JUNIOR trial evaluating children and adolescents, aged 6 to 17 years, living with type 1 diabetes.

Ocular conditions can lead to serious complications, and sometimes there are no early symptoms.

Metformin hydrochloride extended-release tablets are indicated to for improving glycemic control in patients with type 2 diabetes mellitus, as an adjunct to diet and exercise.

Clinical data has illustrated how digital interventions can have a substantial material benefit on glycemic control in users with diabetes, with 73 of 162 users in the study reducing their average blood glucose levels to under 140 mg/dL.

In honor of World Diabetes Day, AstraZeneca has launched the campaign Diabetes Can Break Your Heart, the national movement aimed to change the trajectory of heart failure in type 2 diabetes.

Top news of the day from across the health care landscape.

What is causing this patient to lose her sense of smell?